Purchase of human interleukin 4 for use in NIH protocols from cellgenix USA:1234061 [pots: 20-003224]
Ended Purchase Order Awarded Last action
- Contract number
- 75N90020P00230
- Awardee
-
Cellgenix USA UEI CCYHJN1KNAM6
- Awarding agency
-
NIH Clinical Center
National Institutes of Health, Department of Health and Human Services
- Obligated
- $23,183
Award facts
- Contract value 100% obligated
- $23,182.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Portsmouth, NH 03801, USA
Award details come from SAM.gov/FPDS.
About this award
The National Institutes of Health Clinical Center issued a purchase order to Cellgenix USA for $23,182.50 on February 5, 2020, for human interleukin 4 for use in NIH protocols. The order carries a firm fixed price and concludes on February 14, 2020. Place of performance is Portsmouth, New Hampshire.
Quick answers
Who was awarded contract 75N90020P00230?
75N90020P00230 was awarded to Cellgenix USA by NIH Clinical Center (National Institutes of Health) on February 5, 2020.
How much is contract 75N90020P00230 worth?
The government has obligated $23,183 on 75N90020P00230.
Was contract 75N90020P00230 competed?
The extent of competition for 75N90020P00230 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award